Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iterum Therapeutics (ITRM) Total Current Liabilities (2017 - 2022)

Historic Total Current Liabilities for Iterum Therapeutics (ITRM) over the last 6 years, with Q3 2022 value amounting to $7.5 million.

  • Iterum Therapeutics' Total Current Liabilities fell 5788.32% to $7.5 million in Q3 2022 from the same period last year, while for Sep 2022 it was $7.5 million, marking a year-over-year decrease of 5788.32%. This contributed to the annual value of $12.9 million for FY2021, which is 6896.49% down from last year.
  • Latest data reveals that Iterum Therapeutics reported Total Current Liabilities of $7.5 million as of Q3 2022, which was down 5788.32% from $7.5 million recorded in Q2 2022.
  • Iterum Therapeutics' 5-year Total Current Liabilities high stood at $47.1 million for Q1 2020, and its period low was $7.5 million during Q2 2022.
  • In the last 5 years, Iterum Therapeutics' Total Current Liabilities had a median value of $23.0 million in 2019 and averaged $25.4 million.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first skyrocketed by 36484.87% in 2019, then tumbled by 7820.41% in 2022.
  • Iterum Therapeutics' Total Current Liabilities (Quarter) stood at $12.2 million in 2018, then soared by 202.69% to $37.0 million in 2019, then rose by 12.74% to $41.7 million in 2020, then plummeted by 68.96% to $12.9 million in 2021, then tumbled by 41.98% to $7.5 million in 2022.
  • Its Total Current Liabilities was $7.5 million in Q3 2022, compared to $7.5 million in Q2 2022 and $10.1 million in Q1 2022.